| P50 | author | James Fung | Q41791161 |
| P2093 | author name string | Beom Kyung Kim | |
| | Seung Up Kim | |
| | Man-Fung Yuen | |
| P2860 | cites work | [Clinical factors influencing liver stiffness as measured by transient elastography (Fibroscan) in patients with chronic liver disease] | Q84532659 |
| | Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation | Q84542509 |
| | Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case-control study | Q84590650 |
| | Non‐invasive assessment of liver fibrosis: Time to move from cross‐sectional studies to longitudinal ones | Q84959670 |
| | Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study | Q24680285 |
| | Clinical applications of transient elastography | Q26828052 |
| | An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group | Q29614898 |
| | Management of hepatocellular carcinoma | Q29616230 |
| | Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 |
| | Histological grading and staging of chronic hepatitis | Q29619625 |
| | Complications of cirrhosis. I. Portal hypertension. | Q33870258 |
| | Natural history of hepatitis B virus infection: an update for clinicians | Q34005481 |
| | Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection | Q34154927 |
| | Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation | Q34182393 |
| | Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. | Q34264888 |
| | Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression | Q34365464 |
| | Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. | Q34544284 |
| | Changes of non-invasive markers and FibroScan values during HCV treatment | Q34603736 |
| | Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications | Q35759606 |
| | Assessment of disease progression in patients with transfusion-associated chronic hepatitis C using transient elastography | Q35872121 |
| | Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease | Q36014015 |
| | Does transient elastography (FibroScan®) have a role in decision making in hepatocellular carcinoma? | Q36063323 |
| | Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C. | Q36914350 |
| | Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis | Q36960779 |
| | Non-invasive evaluation of liver fibrosis using transient elastography | Q37107626 |
| | New diagnostic method for liver fibrosis and cirrhosis | Q37188251 |
| | Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study | Q37278294 |
| | Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy | Q37353620 |
| | Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases | Q37386578 |
| | Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. | Q37516476 |
| | Current status of liver diseases in Korea: liver cirrhosis | Q37663511 |
| | Liver transient elastography (Fibroscan): a place in the management algorithms of chronic viral hepatitis | Q37694957 |
| | Decompensated Chronic Heart Failure: Increased Liver Stiffness Measured by Means of Transient Elastography | Q37799179 |
| | Prognostic markers in patients with cirrhosis and portal hypertension who have not bled. | Q37951846 |
| | Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement | Q37951850 |
| | Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma | Q37995306 |
| | Diagnosing and monitoring cirrhosis: Liver biopsy, hepatic venous pressure gradient and elastography. | Q38007674 |
| | Indications for portal pressure measurement in chronic liver disease. | Q38027225 |
| | Factors associated with liver stiffness in chronic liver disease | Q38490064 |
| | The usefulness of transient elastography to diagnose cirrhosis in patients with alcoholic liver disease | Q38495677 |
| | Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. | Q39737270 |
| | Acute viral hepatitis increases liver stiffness values measured by transient elastography | Q40141905 |
| | Reduction of liver stiffness following resolution of acute flares of chronic hepatitis B. | Q41835262 |
| | Use of portal pressure studies in the management of variceal haemorrhage | Q42240290 |
| | Hepatitis B: liver fibrosis and hepatocellular carcinoma | Q42456421 |
| | Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy. | Q42871658 |
| | Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis | Q42925042 |
| | Liver stiffness decrease after effective antiviral therapy in patients with chronic hepatitis C: Longitudinal study using FibroScan | Q42997695 |
| | Reduction of liver stiffness by interferon treatment in the patients with chronic hepatitis C. | Q43126256 |
| | Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease | Q43206886 |
| | Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. | Q43255316 |
| | The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin | Q43472585 |
| | Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study | Q43645660 |
| | Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study. | Q43927506 |
| | A 21-year experience with major hemorrhage after percutaneous liver biopsy | Q44773944 |
| | A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis | Q44778119 |
| | Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis. | Q45187210 |
| | Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease | Q45346653 |
| | Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). | Q45369097 |
| | Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/hepatitis C virus-coinfected patients with cirrhosis. | Q45383974 |
| | Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. | Q45392148 |
| | Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores | Q46242740 |
| | Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. | Q46450252 |
| | Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status | Q47315067 |
| | Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). | Q47428102 |
| | Impact of heart failure and changes to volume status on liver stiffness: non-invasive assessment using transient elastography. | Q51376998 |
| | On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. | Q51584406 |
| | Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. | Q51830742 |
| | Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis. | Q53367837 |
| | Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. | Q53384141 |
| | [Liver stiffness measurement for the diagnosis of hepatic fibrosis in patients with chronic viral hepatitis]. | Q53554274 |
| | [Comparison of terlipressin and octreotide with variceal ligation for controlling acute esophageal variceal bleeding--a randomized prospective study]. | Q53588196 |
| | [A prospective study comparing the efficacy of early administration of terlipressin and somatostatin for the control of acute variceal bleeding in patients with cirrhosis]. | Q53588201 |
| | Chronic hepatitis. An update on terminology and reporting. | Q53635198 |
| | [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea] | Q57211607 |
| | Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B | Q58235821 |
| | Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs | Q58815702 |
| | Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension | Q59288251 |
| | A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis | Q59621805 |
| | Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases | Q61054091 |
| | Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C | Q61763020 |
| | Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis | Q61763027 |
| | The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific | Q63432580 |
| | Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis | Q74784718 |
| | Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices | Q79781279 |
| | Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage | Q80245191 |
| | [Prevention of variceal bleeding and measurement of hepatic vein pressure gradient] | Q80336190 |
| | [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations] | Q80513240 |
| | [Usefulness of liver stiffness measurement for predicting the presence of esophageal varices in patients with liver cirrhosis] | Q82061576 |
| | Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis | Q82214451 |
| | Liver stiffness is directly influenced by central venous pressure | Q82292984 |
| | Liver stiffness measurements in acute hepatitis B: implications for clinical practice | Q82451751 |
| | Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations | Q82829717 |
| | Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan® | Q82980218 |
| | Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study | Q83482709 |
| | Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B | Q83868014 |
| | Noninvasive diagnosis of large esophageal varices by Fibroscan: strong influence of the cirrhosis etiology | Q84240499 |
| | Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B | Q84328358 |
| | The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B | Q84355130 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| | chronic liver disease | Q5113984 |
| P304 | page(s) | 1890-1900 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives | |
| P478 | volume | 19 | |